APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 148 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 3.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,425,050 | -87.1% | 63,750 | -69.0% | 0.06% | -85.9% |
| Q2 2023 | $18,747,833 | +121.8% | 205,794 | +60.6% | 0.41% | +137.6% |
| Q1 2023 | $8,453,302 | +62.5% | 128,158 | +27.4% | 0.17% | +43.0% |
| Q4 2022 | $5,202,026 | -42.3% | 100,600 | -23.8% | 0.12% | -46.2% |
| Q3 2022 | $9,023,000 | +213.4% | 132,100 | +107.5% | 0.22% | +196.1% |
| Q2 2022 | $2,879,000 | -11.7% | 63,665 | -0.8% | 0.08% | +1.3% |
| Q1 2022 | $3,262,000 | +213.7% | 64,200 | +191.8% | 0.08% | +212.5% |
| Q4 2021 | $1,040,000 | -66.3% | 22,000 | -76.5% | 0.02% | -71.8% |
| Q3 2021 | $3,088,000 | -28.4% | 93,671 | +37.3% | 0.08% | -38.4% |
| Q2 2021 | $4,310,000 | +1603.6% | 68,200 | +621.8% | 0.14% | +557.1% |
| Q1 2020 | $253,000 | -26.2% | 9,448 | -63.7% | 0.02% | -58.0% |
| Q4 2018 | $343,000 | – | 26,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |